Navigation Links
Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
Date:5/18/2011

or many patients.  I am especially optimistic that PT003 has the potential of fulfilling this unmet need for COPD patients at all stages of severity."

Expanding the benefits beyond its primary endpoint, PT003 also demonstrated a statistically significant improvement in peak FEV1 on day one, with further benefit observed on day seven relative to all comparators and placebo. Treatment with PT003 yielded an improvement in peak FEV1 levels of 42% (or 64 mL) over Foradil and 74% (or 92 mL) over Spiriva as measured on day one; and an improvement of 37% (or 89 mL) over Foradil and 75% (or 141 mL) over Spiriva when measured on day seven (p<0.03 for all comparisons). Furthermore, PT003 demonstrated a faster onset of action than did Spiriva on day one (75% higher probability of onset at any time point during the first 2 hours following administration, p</=0.0003).

PT003 also demonstrated a significant improvement in morning trough FEV1, which is a measure of lung function in patients before they receive their first dose of medication in the morning. This is a particularly relevant measurement for COPD patients who often report that their symptoms are most severe in the morning and cause them to struggle with morning activities. In this Phase 2b study, following one week of study medication, morning trough FEV1 levels in the PT003 arm were improved by 48% (or 68 mL) over Foradil and 52% (or 73 mL) over Spiriva (p<0.014 for both measures).

"The overall improvement in lung function, including the fast onset of action with higher peak improvements in FEV1 and morning trough FEV1 is a strong indicator of how PT003's twice-a-day dosing can benefit patients' disease management," continued Dr. Reisner. "To assess the full clinical potential of PT003, and ensure that we have the strongest possible regulatory package, we plan to initiate four additional Phase 2b studies in the next few weeks. These studies will further
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
2. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
3. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
4. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
5. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
6. Regency Therapeutics and Daiichi Sankyo Announce Launch and Commercial Availability of SPRIX® (ketorolac tromethamine) Nasal Spray
7. Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
8. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
9. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
10. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
11. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "Micro Market Monitor: North ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is progressing steadily, which has resulted in fueling ... market. The main purpose of these dermatology devices ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Nov. 1, 2011 Daylight Saving Time comes to an end ... altering sleep patterns. Sixty percent of Americans say that they experience ... the National Sleep Foundation,s 2011 Sleep in America poll, and for ... This season, fall back into bed for not only ...
... Calif., Nov. 1, 2011 Telik, Inc. (Nasdaq: ... studies on Telintra and related analogs at the 2011 ... and Cancer Therapeutics in San Francisco, California.  Details of ... Novel Ezatiostat analogues disrupt binding of GSTP1 to ...
Cached Medicine Technology:Keep the Time Change From Disrupting Your Rest With Sleep Formula 39™ 2Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2
(Date:12/20/2014)... 2014 An improving macroeconomic landscape and ... the Massage Services industry over the five ... products, the anticipated 1.0% annualized increase in per capita ... with the means to afford additional massages. “While the ... in a given year has declined from 2009 to ...
(Date:12/20/2014)... The print component of Healthy Aging is distributed ... 160,000 copies and an estimated readership of 420,000. The ... media strategy and across a network of top news ... of the campaign, click here . , The ... of CTV’s The Social. Lainey Lui, Melissa Grelo, ...
(Date:12/20/2014)... The Doctor’s Office Urgent Care of Paramus, New Jersey has ... They’ve treated over 40,000 patients while carrying out their ... to the Paramus area. , For 2015, the practice ... of top-notch board certified physicians: Christine Milosis MD, Sandra Ugras ... doctors will work tirelessly to carry out The Doctor’s ...
(Date:12/20/2014)... Atore, Inc, (San Francisco, CA CEO: Masashi ... focused portal on December 17th, 2014. , One ... US and Japan. , MERRY BIRTHDAY SITE : ... , MERRY BIRTHDAY MESSAGE is part of 5 future ... Features, Choose from thousands of stock photos to decorate ...
(Date:12/20/2014)... Aliso Viejo, California (PRWEB) December 20, 2014 ... have announced the release of a new plugin for ... Pixel Film Studios. , “TranSlice Volume 5 allows users ... literally hand draw it.” Said Christina Austin, CEO of ... to add level of professionalism while maintaining an easy ...
Breaking Medicine News(10 mins):Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... 5, ... Boston, BOSTON, ... Insight Award for Customer Advocacy in,Healthcare. First presented in 2006, the Award ... fully informed choices and successful purchase decisions. This year,s finalists are:, ...
... MERRIMAC, Mass., Oct. 9 Nurse Savvy Research ... healthcare. Nursesavvy.com is an online medical information ... based recommendations as to which,doctors they would choose ... healthcare for everyone. The data gathered for the ...
... NEW YORK, Oct. 9 MGT Capital ... company focused on the Healthcare Information,Technology ("HCIT") ... subsidiary company Medicexchange PLC, a global web ... for diagnostic, treatment and,surgery planning solutions across ...
... Announces International Office Development in ... ... (Pink,Sheets: AWTM), through its wholly owned subsidiary AWT International, Inc.,has opened ... medical equipment and general,supplies to the U.S. healthcare industry. The ...
... source of frustration, study finds , TUESDAY, Oct. 9 (HealthDay ... Hispanics, ability to get good health care, a new study ... difficulty navigating the health care system, say researchers reporting in ... In this study, a team led by Robert Weech-Maldonado, an ...
... Two UT Southwestern Medical Center researchers a distinguished ... elected to the Institute of Medicine, a component of ... Luis Parada, professor and chairman of developmental biology, and ... among 65 new national members and four foreign associates ...
Cached Medicine News:Health News:Nursesavvy.com Promoting Quality Healthcare for Everyone 2Health News:MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC 2Health News:MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC 3Health News:AWT, Inc. Continues Rapid Expansion in Middle East 2Health News:AWT, Inc. Continues Rapid Expansion in Middle East 3Health News:Many U.S. Hispanics Struggle With Health Care System 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 3
... HEp-2000 ANA uses a patented HEp-2 ... to increase the sensitivity to SS-A/Ro autoantibodies, ... Several independent studies have been published worldwide ... increased sensitivity to SS-A/Ro autoantibodies when used ...
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
... Indirect Fluorescence Assay (IFA) for IgG ... for the qualitative and semi-quantitative detection ... in human serum. Detection of ANA ... an aid in the diagnosis of ...
Medicine Products: